The independent expert has concluded that the Scheme is NOT FAIR...therefore in the best interests of Beadell shareholders.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025